Displaying 69 out of 2,369 Health Tech companies
 Filter
City
Country
Stage
Business Model
Industry
company score funding investors employees industries biz model city contact
Eligo Bioscience

Gene-editing platform.

89
$30M · Series B Sanofi Ventures, Khosla Ventures, Bpifrance 11 to 50 Health Tech, Biotech Paris, France •••••••••••@eligo.bio
Automata

Workflow automation platform for the life sciences industry.

84
$40M · Series B Dimension, Local Globe, Hummingbird Ventures 51 to 100 Health Tech, Machine Learning B2B London, UK •••••••••••@automata.tech
Causaly

Biomedical research discovery tool.

84
$60M · Series B Index Ventures, ICONIQ Growth, Pentech Ventures 51 to 100 Health Tech, AI, Biotech, Pharma B2B, SaaS London, UK •••••••••••@causaly.com
Moon Surgical

Robots for surgery.

84
$55M · Series B Sofinnova Partners, Cathay Innovation 11 to 50 Health Tech, Hardware, Deep Tech, Robotics, Manufacturing B2B Paris, France •••••••••••@moonsurgical.com
Orbis Medicines

Oral macrocycle drug discovery platform.

84
$28M · Seed Novo A/S, Forbion Capital Partners 1 to 10 Health Tech, Biotech B2B Copenhagen, Denmark •••••••••••@orbismedicines.com
GetHarley

Skin care telehealth platform.

84
$52M · Series B Village Global, Index Ventures, Headline 101 to 250 Health Tech B2C London, UK •••••••••••@getharley.com
Beacon Therapeutics

Oophthalmic gene therapy company to treat blinding retinal illnesses.

84
$120M · Series A Syncona Partners LLP 1 to 10 Health Tech, Biotech London, UK •••••••••••@beacontx.com
CarThera

Ulltrasound-based medical devices manufacturer to treat various brain disorders.

79
$4M · Series B Unorthodox Ventures, EIC Accelerator, Panakes Partners 1 to 10 Health Tech, Hardware B2C Paris, France •••••••••••@carthera.eu
Cera

Cera Care is a London-based technology-enabled home care company.

79
$64M Oltre Venture 5001 to 10000 Health Tech, Mobile, Service Industry, ElderTech B2B, B2C London, UK •••••••••••@ceracare.co.uk
Corti

AI-driven services that aid healthcare providers in delivering timely, accurate care.

79
$60M · Series B Atomico, Eurazeo, Prosus & Naspers 51 to 100 Health Tech, Machine Learning B2B, SaaS Copenhagen, Denmark •••••••••••@corti.ai
CorWave

Innovative heart pumps manufacturer.

79
$28M · Series C Bpifrance, Sofinnova Partners, Ysios Capital 51 to 100 Health Tech, Hardware B2B Paris, France •••••••••••@corwave.com
Gleamer

AI software for radiologists.

79
$29M · Series B Bpifrance, Heal Capital, Elaia 1 to 10 Health Tech, AI B2B Paris, France •••••••••••@gleamer.ai
MinervaX

Developer of prophylactic vaccine against Group B Streptococcus.

79
$57M · Series C EQT Partners, OrbiMed, Novo A/S 1 to 10 Health Tech, Biotech B2B Copenhagen, Denmark •••••••••••@minervax.com
Mnemo Therapeutics

Mnemo Therapeutics specializes in biotechnology and life science.

79
$89M · Series A Sofinnova Partners 101 to 250 Health Tech, Biotech B2B Paris, France •••••••••••@mnemo-tx.com
Payfit

Payfit allows small and medium enterprises to easily and quickly pay their employees.

79
$79M · Series C Accel, Eurazeo 251 to 500 Health Tech B2B, SaaS Paris, France •••••••••••@payfit.com
SparingVision

SparingVision is a biotechnology company focused development of genomic medicines for the treatment of blinding inherited retinal diseases.

79
$52M · Series A Ysios Capital 1 to 10 Health Tech, Biotech, Deep Tech B2B Paris, France •••••••••••@sparingvision.com
Withings

Withings is a developer of digital health and wellness smart devices such as fitness trackers and watches.

79
$60M · Series B 2050 101 to 250 Health Tech, Hardware, Sportstech, Mobile, Manufacturing, Wearables B2B Paris, France •••••••••••@withings.com
Neko Health

Preventative health care platform.

79
$65M · Series A General Catalyst, Atomico, Lakestar 11 to 50 Health Tech B2C Stockholm, Sweden •••••••••••@nekohealth.com
Luma Vision

4D cardiac imaging and navigation platform.

79
$21M · Series A EQT Life Sciences, EIC Accelerator, imec.xpand 11 to 50 Health Tech B2B, SaaS Dublin, Ireland •••••••••••@lumavision.com
MIP Discovery

Developer of non-biological affinity reagents to accelerate the production of cell and gene therapies.

79
$8M · Series A Mercia Asset Management 11 to 50 Health Tech, Biotech London, UK •••••••••••@mipdiscovery.com
Sorella Care

Digital health platform for women.

79
$5M · Seed Blisce, Vorwerk Ventures 1 to 10 Health Tech B2C, SaaS Paris, France •••••••••••@sorella-care.com
Curve Therapeutics

Intracellular screening platform.

76
$51M · Series A Columbus Venture Partners, British Patient Capital, Pfizer Venture Investments 11 to 50 Health Tech Southampton, UK •••••••••••@curvetx.com
Argá Medtech

Cardiac ablation system developer for treating cardiac arrhythmias.

76
$58M · Series B Advent Life Sciences, Gilde Healthcare, Earlybird Venture Capital 1 to 10 Health Tech Lausanne, Switzerland •••••••••••@argamedtech.com
AMSilk

Developer of bio-fabricated silk protein materials.

75
$27M · Series C Novo A/S 11 to 50 Health Tech, Biotech, Manufacturing B2B Munich, Germany •••••••••••@amsilk.com
Carrick Therapeutics

Clinical-stage biopharmaceutical company.

75
$95M · Series A Lightstone, GV, ARCH Venture Partners 51 to 100 Health Tech, Deep Tech B2C Dublin, Ireland •••••••••••@carricktherapeutics.com
CatalYm

Innovative immunotherapies developer for cancer patients.

75
$51M Forbion Capital Partners, Vesalius Biocapital Partners, Novartis Venture Fund 11 to 50 Health Tech, Biotech, Manufacturing B2B Munich, Germany •••••••••••@catalym.com
Enterome

Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.

75
$3M · Series F The Leukemia & Lymphoma Society’s Therapy Acceleration Program, Omnes Capital, Nestlé Health Science 51 to 100 Health Tech, Biotech, Deep Tech, Pharma B2B Paris, France •••••••••••@enterome.com
Huma

Huma provides a digital health platform used for predictive care and research.

75
$25M · Series B Unilever Ventures, Samsung NEXT 101 to 250 Health Tech, Data and Analytics, Business Intelligence B2B, SaaS London, UK •••••••••••@huma.com
Lassie

Digital pet insurance platform.

75
$25M · Series B Balderton Capital, Felix Capital, Inventure 1 to 10 Health Tech, Pet Tech B2C, Marketplace Stockholm, Sweden •••••••••••@lassie.co
Lifen

Lifen is your simple and secure exchange of medical letters assistant.

75
$22M · Series B Daphni, Partech Ventures, Serena 11 to 50 Health Tech, Hardware B2B, SaaS Paris, France •••••••••••@lifen.fr
Ori Biotech

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.

75
$30M · Series A Kindred Capital, Octopus Ventures, Amadeus Capital 1 to 10 Health Tech, Biotech, Manufacturing B2B London, UK •••••••••••@oribiotech.com
Oviva

Oviva digitizes the treatment of type 2 diabetes and obesity through a unique behavior change platform.

75
$21M · Series B AlbionVC, Earlybird Venture Capital, Partech Ventures 251 to 500 Health Tech, Foodtech, CPG & Consumer Goods, Ecommerce B2B London, UK •••••••••••@oviva.com
Oxford Medical Simulation

Virtual reality healthcare training platform.

75
$12M · Series A Frog Capital, ACF Investors, QVentures 1 to 10 Health Tech, Edtech B2B, SaaS London, UK •••••••••••@oxfordmedicalsimulation.com
Quell Therapeutics

Quell Therapeutics is a cell therapy company

75
$45M · Series A AlbionVC, Point72 Ventures 101 to 250 Health Tech, Edtech, Biotech, Manufacturing B2B London, UK •••••••••••@quell-tx.com
Sekoia

Cybersecurity platform.

75
$37M · Series A Northcap 101 to 250 Health Tech, Hardware, Cybersecurity, Manufacturing B2B, SaaS Paris, France •••••••••••@sekoia.io
Tilak Healthcare

Remote monitoring system for ophthalmic conditions.

75
$10M · Series A Elaia, iBionext, Cap Horn 11 to 50 Health Tech B2C Paris, France •••••••••••@tilakhealthcare.com
Acesion Pharma

Therapy to treat atrial fibrillation (AF).

75
$47M · Series B Canaan Partners, Novo A/S, Broadview Ventures 1 to 10 Health Tech Copenhagen, Denmark •••••••••••@acesionpharma.com
Orbem

AI-powered MRI platform for scanning biological samples.

75
$31M · Series A 83North, TVC, Possible Ventures 51 to 100 Health Tech, AI B2B, SaaS Munich, Germany •••••••••••@orbem.ai
Basecamp Vascular

Mechatronic guidewires manufacturer.

75
$6M · Series A Forepont Capital Partners, NTI Corporation 11 to 50 Health Tech, Hardware B2B Paris, France •••••••••••@basecampvascular.com
Hoba Therapeutics

Therapeutic protein developer for chronic neuropathic pain.

75
$24M · Series A Medical Incubator Japan, Borean Innovation, Novo A/S 1 to 10 Health Tech, Biotech Copenhagen, Denmark •••••••••••@hobatherapeutics.com
IMU Biosciences

AI platform to map the human immune system.

75
$14M · Series A Molten Ventures, Life Extension Ventures 11 to 50 Health Tech, Biotech London, UK •••••••••••@imubiosciences.com
Scinvivo

Developer of imaging catheters based on optical coherence tomography (OCT) for cancer treatment.

75
$5M · Series A Santec Corporation, NLC 1 to 10 Health Tech, Deep Tech B2B Amsterdam, Netherlands •••••••••••@scinvivo.com
Aktiia

AI-powered hypertension management platform.

71
$30M · Series A Khosla Ventures, Molten Ventures, Translink Capital 51 to 100 Health Tech, AI B2C, SaaS Bern, Switzerland •••••••••••@aktiia.com
Achilles Therapeutics

Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

68
$17M · Seed AlbionVC, Boxer Capital, Syncona Partners LLP 101 to 250 Health Tech, Biotech B2B London, UK •••••••••••@achillestx.com
Babylon Health

AI-Powered healthcare platform.

68
$5M · Seed Hoxton Ventures, eHealth Ventures, AlbaCore Capital 1001 to 5000 Health Tech, AI B2B, B2C London, UK •••••••••••@babylonhealth.com
Capitainer

Self-sampling technology.

68
$2M · Series A Sciety, We Venture Capital 1 to 10 Health Tech B2C Stockholm, Sweden •••••••••••@capitainer.se
Charm Therapeutics

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

68
$50M · Series A Khosla Ventures, General Catalyst 1 to 10 Health Tech, AI, Biotech, Data and Analytics B2B London, UK •••••••••••@charmtx.com
Cobee

Employee benefits management platform.

68
$40M Balderton Capital, Notion Capital, Speedinvest 51 to 100 Health Tech, Fintech B2B, SaaS Madrid, Spain •••••••••••@cobee.io
Egle Therapeutics

Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

68
$46M Bioqube Ventures 11 to 50 Health Tech, Biotech B2B Paris, France •••••••••••@egle-tx.com
Entia

At-home blood testing platform for cancer patients.

68
$17M · Series A Business Growth Fund, Parkwalk Advisors 11 to 50 Health Tech B2B London, UK •••••••••••@entia.co
Eyevensys

Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases.

68
$30M · Series B Pureos Bioventures, Karista 11 to 50 Health Tech, Hardware, Biotech, Manufacturing B2B Paris, France •••••••••••@eyevensys.com
FIRE1

Heart failure management app and devices.

68
$44M · Series C Lightstone, Gilde Healthcare, New Enterprise Associates 1 to 10 Health Tech, Deep Tech B2C Dublin, Ireland •••••••••••@fire1foundry.com
Flo Health

Flo is an AI-powered women’s health app that supports women at every stage of their reproductive cycle.

68
$7M · Series A Target Global, VNV Global 251 to 500 Health Tech, Mobile, Business Intelligence B2C, Freemium London, UK •••••••••••@flo.health
Fresha

Fresha provides an online platform for booking beauty and wellness appointments with local businesses.

68
$20M · Series B Partech Ventures, Target Global, FJ Labs 251 to 500 Health Tech, Fashion, Ecommerce B2B, B2C, SaaS London, UK •••••••••••@fresha.com
HelloSelf

Therapy and coaching platform.

68
$20M · Series B Omers Ventures, Octopus Ventures 51 to 100 Health Tech, Fitness B2B, B2C, Marketplace London, UK •••••••••••@helloself.com
Hemab

Treatments for genetic bleeding disorders.

68
$135M · Series B Novo A/S, HealthCap 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Copenhagen, Denmark •••••••••••@hemab.com
Hublo

Hublo provides software that ease healthcare professionals daily life so that they can focus on taking care of patients.

68
$25M · Series A Revaia, Acton Capital 51 to 100 Health Tech B2B, SaaS Paris, France •••••••••••@hublo.com
Kheiron

We’re going where no-one has ever gone before. -- We’re fighting cancer. -- Lives are at stake.

68
$22M · Series A Hoxton Ventures, Atomico, Connect Ventures 11 to 50 Health Tech, AI B2B London, UK •••••••••••@kheironmed.com
LabGenius

LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine.

68
$25M Kindred Capital, Atomico 51 to 100 Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing B2B London, UK •••••••••••@labgeni.us
Leyden Labs

Manufacturer of medicines to protect from the threat of respiratory viruses

68
$47M SoftBank Group, GV 11 to 50 Health Tech, Biotech, Deep Tech B2B Amsterdam, Netherlands •••••••••••@leydenlabs.com
Lindus Health

Clinical trials platform.

68
$18M · Series A Valar Ventures, Creandum, Seedcamp 11 to 50 Health Tech, Biotech B2B, SaaS London, UK •••••••••••@lindushealth.com
Nabla

Digital care. Superpowered. Build engaging relationships with your patients through our machine learning-powered care platform.

68
$20M Firstminute Capital 11 to 50 Health Tech, AI, Mobile B2C Paris, France •••••••••••@nabla.com
NorthSea Therapeutics

Innovative therapeutic drugs to treat inflammatory, metabolic and liver diseases.

68
$27M · Series A Sofinnova Partners, Novo A/S, Forbion Capital Partners 11 to 50 Health Tech, Biotech B2B Amsterdam, Netherlands •••••••••••@northseatherapeutics.com
Numan

Numan is a startup which aims to tackle your tackle problem erectile dysfunction.

68
$12M · Series A Anthemis, VNV Global 11 to 50 Health Tech, Edtech B2C London, UK •••••••••••@numan.com
Ouihelp

Ouihelp is a developer of an online residential assistance platform designed to help seniors in their regular activities at home.

68
$31M · Series B Future Positive Capital, XAnge 51 to 100 Health Tech B2B, B2C, Marketplace Paris, France •••••••••••@ouihelp.fr
Palta

Palta is a health and wellbeing technology company

68
$14M · Series A Target Global, VNV Global 501 to 1000 Health Tech, Mobile B2B, B2C London, UK •••••••••••@palta.com
ReViral

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

68
$44M · Series C Novo A/S, Andera Partners 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@reviral.co.uk
SafeHeal

SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.

68
$47M Sofinnova Partners 1 to 10 Health Tech, Hardware, Pharma, Manufacturing B2B Paris, France •••••••••••@safeheal.com
Sonio

AI-powered prenatal screening solution.

68
$14M · Series A Bpifrance, Elaia, EIC Accelerator 11 to 50 Health Tech, Deep Tech SaaS Paris, France •••••••••••@sonio.ai

Seedtable’s take on Health Tech

By Gonz Sánchez Sarmiento
CEO at Seedtable

Health Tech in Europe is a rapidly growing industry that is transforming medicine. Some of the trends powering this transformation include AI in healthcare, an increased focus on patient data, staff wellness, remote healthcare, and wearables. However, Europe is facing substantial challenges in continuing to deliver high-quality healthcare services to its citizens, including ageing populations, cultural shifts, rigid and complex financing models, increasing costs of innovation, a scarcity of skilled personnel, rising health inequalities, and health complexities stemming from climate change. The European Union has implemented the Regulation on Health Technology Assessment (HTA) to improve the quality of HTA across the Union and ensure an efficient use of resources. The European digital health market is predicted to grow at a CAGR of 27.1% from 2020 to 2025, with the UK, Germany, and France being the largest markets. The use of data and technology in the healthcare and life sciences sectors is expected to continue to enhance the industry, with artificial intelligence and machine learning playing a central role. However, the industry is fragmented, especially when it comes to rules and operational standards across the continent, making it challenging to establish a legal basis to allow the exchange of health data.

OTHER INDUSTRIES
Other Health Tech startups by location